Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimum
ClinicalTrials.gov study NCT01185288. IPD Sharing: Not stated. Countries: 2. Publications: 6.
A Study of Mavrilimumab in Subjects With Moderate-to-Severe Rheumatoid Arthritis
ClinicalTrials.gov study NCT01706926. IPD Sharing: Not stated. Countries: 14. Publications: 1.
Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study
ClinicalTrials.gov study NCT02441218. IPD Sharing: YES. Countries: 2. Publications: 4.
Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor
ClinicalTrials.gov study NCT02006654. IPD Sharing: Not stated. Countries: 15. Publications: 3.
Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia
ClinicalTrials.gov study NCT00229619. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis
ClinicalTrials.gov study NCT02931838. IPD Sharing: Not stated. Countries: 8. Publications: 4.
A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain
ClinicalTrials.gov study NCT03213457. IPD Sharing: YES. Countries: 3. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
ClinicalTrials.gov study NCT04294667. IPD Sharing: YES. Countries: 25. Publications: 0.
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT03598790. IPD Sharing: YES. Countries: 13. Publications: 10.
A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03875482. IPD Sharing: YES. Countries: 2. Publications: 1.
A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis
ClinicalTrials.gov study NCT05364554. IPD Sharing: YES. Countries: 10. Publications: 2.
Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain
ClinicalTrials.gov study NCT01961271. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Study to Assess the Effects of PT003 and Placebo MDI on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD
ClinicalTrials.gov study NCT02643082. IPD Sharing: YES. Countries: 1. Publications: 1.
Effectiveness of Deep Versus Moderate Neuromuscular Blockade
ClinicalTrials.gov study NCT03266419. IPD Sharing: NO. Countries: 1. Publications: 1.
Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection
ClinicalTrials.gov study NCT04784559. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
ClinicalTrials.gov study NCT02006641. IPD Sharing: Not stated. Countries: 19. Publications: 3.
A Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD)
ClinicalTrials.gov study NCT03488030. IPD Sharing: YES. Countries: 1. Publications: 1.
CyclASol for the Treatment of Moderate to Severe Dry-eye Disease (DED)
ClinicalTrials.gov study NCT02617667. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of the Efficacy and Safety of Upadacitinib in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biolog
ClinicalTrials.gov study NCT03345849. IPD Sharing: YES. Countries: 49. Publications: 7.
5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis
ClinicalTrials.gov study NCT00120523. IPD Sharing: NO. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.